» Articles » PMID: 21191513

Dietary Approaches Following Endoscopic Retrograde Cholangiopancreatography: A Survey of Selected Endoscopists

Overview
Date 2010 Dec 31
PMID 21191513
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To describe the dietary recommendations of experienced endoscopists for patients who have undergone endoscopic retrograde cholangiopancreatography (ERCP) and the factors that influence these recommendations.

Methods: Selected U.S. endoscopists with ERCP experience were surveyed by e-mail. A questionnaire with three hypothetical ERCP cases of patients at low, medium and high risk for development of post-ERCP pancreatitis (PEP) was shown. For each scenario, respondents were asked to recommend a post-procedure diet and time to first oral intake. Respondents were also asked about the effect of various clinical factors on their recommendations, including risk of PEP.

Results: 97/187 selected ASGE members (51.9%) responded. When risk of PEP was either low, medium or high, 53%, 88% and 96% recommended a diet of clear liquids/NPO respectively, and 2%, 5% and 18% recommended delaying first oral intake until the following day. About 88% of respondents gave the same type of diet to patients at high as those with moderate-risk of PEP (P = 0.04). However, 37% and 43% of respondents gave different types of diet to patients at low vs moderate-risk and low-risk vs high-risk of PEP respectively (P < 0.001). No statistically significant associations were found regarding the effect of other clinical factors or respondent demographics.

Conclusion: Most experienced endoscopists limit diet to NPO/clear liquids after ERCP for patients at high or moderate risk of post-ERCP pancreatitis. About half allow a low-fat or regular diet in patients at low risk.

Citing Articles

Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study.

Wang R, Wang W, Ma K, Duan X, Wang F, Huang M Front Pharmacol. 2020; 11:1252.

PMID: 32973503 PMC: 7466563. DOI: 10.3389/fphar.2020.01252.

References
1.
Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M . Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001; 96(2):417-23. DOI: 10.1111/j.1572-0241.2001.03594.x. View

2.
Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano M, Spirito F . Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007; 102(8):1781-8. DOI: 10.1111/j.1572-0241.2007.01279.x. View

3.
Freeman M, Nelson D, Sherman S, Haber G, Fennerty M, DiSario J . Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) Study Group. Gastrointest Endosc. 1999; 49(5):580-6. DOI: 10.1016/s0016-5107(99)70385-8. View

4.
Freeman M, Nelson D, Sherman S, Haber G, Herman M, Dorsher P . Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996; 335(13):909-18. DOI: 10.1056/NEJM199609263351301. View

5.
Freeman M, DiSario J, Nelson D, Fennerty M, Lee J, Bjorkman D . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001; 54(4):425-34. DOI: 10.1067/mge.2001.117550. View